Cellular death in hippocampus in response to PI3K pathway inhibition and oxygen and glucose deprivation

Ana Paula Horn1, Daniéli Gerhardt, Augusto Bencke Geyer

  • 1Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, RS, Brazil.

Insights

The phosphoinositide3-kinase (PI3K) pathway inhibition did not replicate ischemic cell death in hippocampal organotypic cultures. PI3K inhibition caused cell death in both CA1 and dentate gyrus (DG) regions, unlike ischemia.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • The phosphoinositide 3-kinase (PI3K) pathway is crucial for cell survival and growth.
  • Understanding its role in neuronal injury is vital for developing neuroprotective strategies.

Purpose of the Study:

  • To investigate the role of the PI3K pathway in hippocampal CA1 and dentate gyrus (DG) regions under ischemic conditions.
  • To compare the effects of PI3K inhibition with oxygen and glucose deprivation (OGD) on neuronal viability.

Main Methods:

  • Organotypic hippocampal slice cultures were treated with LY294002 (a PI3K inhibitor) or subjected to 60 minutes of OGD.
  • Cell death was assessed by propidium iodide (PI) uptake and caspase 3/7 activity.
  • AKT phosphorylation and immunocontent were analyzed.

Main Results:

  • LY294002 induced cell death in both CA1 and DG, with a more rapid onset in DG.
  • OGD primarily caused cell death in the CA1 region, starting 13 hours post-insult.
  • No significant changes in AKT phosphorylation were observed following OGD, suggesting it is not directly linked to ischemic damage.

Conclusions:

  • PI3K pathway inhibition does not fully mimic the cell death patterns observed in ischemic conditions.
  • Neuronal damage following ischemia involves complex mechanisms beyond PI3K pathway inhibition.
  • The PI3K pathway's role in neuronal survival under ischemic stress requires further elucidation.

Related Concept Videos

Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...